Borderline Resectable Pancreatic Adenocarcinoma
specificA pancreatic ductal adenocarcinoma term that refers to a continuum between resectable and locally advanced unresectable disease.
6
Centers
4
Active Trials
—
Cancer Funding
Top Centers for Borderline Resectable Pancreatic Adenocarcinoma(6)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 65.8 |
| 2 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 65.8 |
| 3 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 65.8 |
| 4 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 65.8 |
| 5 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 43.3 |
| 6 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 43.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →